Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. PharmaSGP Holding SE
  6. Summary
    PSG   DE000A2P4LJ5

PHARMASGP HOLDING SE

(PSG)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
25.6(c) 24.9(c) 24.6(c) 24.6(c) 24.3(c) Last
477 1 630 497 100 1 068 Volume
+2.40% -2.73% -1.20% 0.00% -1.22% Change
More quotes
Estimated financial data (e)
Sales 2021 61,4 M 69,4 M 69,4 M
Net income 2021 9,30 M 10,5 M 10,5 M
Net Debt 2021 68,6 M 77,6 M 77,6 M
P/E ratio 2021 32,0x
Yield 2021 0,95%
Sales 2022 74,8 M 84,6 M 84,6 M
Net income 2022 9,25 M 10,5 M 10,5 M
Net Debt 2022 57,0 M 64,5 M 64,5 M
P/E ratio 2022 31,0x
Yield 2022 0,97%
Capitalization 292 M 330 M 330 M
EV / Sales 2021 5,87x
EV / Sales 2022 4,66x
Nbr of Employees 63
Free-Float 22,2%
More Financials
Company
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products. 
Sector
Other Specialty Retailers
Calendar
-
More about the company
Ratings of PharmaSGP Holding SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PHARMASGP HOLDING SE
11/16PharmaSGP reporting 34% revenue growth and increased profitability in Q3 2021
EQ
09/16PHARMASGP : Product portfolio further expanded and internationalisation driven forward in ..
EQ
09/16PharmaSGP Holding SE Announces Financial Results for the First Half of 2021
CI
09/15PharmaSGP Holding SE Raises Financial Forecast for Fiscal Year 2021
CI
08/31PHARMASGP : GSK Closes Sale of Four OTC Brands to PharmaSGP
MT
08/31PHARMASGP : completes acquisition of OTC brand portfolio (Baldriparan(R), Formigran(R), Sp..
EQ
06/28PHARMASGP HOLDING SE : Notification and public disclosure of transactions by persons
EQ
06/25PHARMASGP : successfully holds first AGM after IPO
EQ
06/20Certain Bearer Shares of PharmaSGP Holding SE are subject to a Lock-Up Agreement Ending..
CI
06/15GLAXOSMITHKLINE : to Sell Four OTC Brands to PharmaSGP in $97 Million Deal
MT
06/15PHARMASGP : acquires OTC brand portfolio (Baldriparan, Formigran, Spalt  and Kamol) from G..
EQ
05/18PHARMASGP : Expected business development in Q1 2021
EQ
05/18PharmaSGP Holding SE Provides Earnings Guidance for 2021
CI
05/18PharmaSGP Holding SE Reports Preliminary Earnings Results for the First Quarter of 2021
CI
03/31PHARMASGP : Revenue growth in 2020 despite declining markets
EQ
More news
News in other languages on PHARMASGP HOLDING SE
11/16PharmaSGP mit 34% Umsatzwachstum sowie Steigerung der Profitabilität in Q3 2021
11/16PharmaSGP mit 34% Umsatzwachstum sowie Steigerung der Profitabilität in Q3 2021
10/18PHARMASGP HOLDING SE : Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweit..
10/18PharmaSGP Holding SE
10/12PharmaSGP Holding SE
More news
Chart PHARMASGP HOLDING SE
Duration : Period :
PharmaSGP Holding SE Technical Analysis Chart | PSG | DE000A2P4LJ5 | MarketScreener
Technical analysis trends PHARMASGP HOLDING SE
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 24,30 €
Average target price 34,50 €
Spread / Average Target 42,0%
EPS Revisions
Managers and Directors
Natalie Weigand Chief Executive Officer
Michael Rudolf Chief Financial Officer
Clemens Fischer Chairman-Supervisory Board
Madlena Hohlefelder Deputy Chairman-Supervisory Board
Axel Rebien Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
PHARMASGP HOLDING SE-6.54%330
ULTA BEAUTY, INC.39.13%21 717
L BRANDS114.90%19 725
E.L.F. BEAUTY, INC.23.34%1 617
SA SA INTERNATIONAL HOLDINGS LIMITED49.59%720
BEAUTY GARAGE INC.38.49%212